Article
Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
Human pathology - 1 Jun 2022
Righi Simona, Novero Domenico, Godio Laura, Bertuzzi Clara, Bacci Francesco, Agostinelli Claudio, Sagramoso Carlo, Rossi Maura, Piccioli Milena, Gazzola Anna, Mannu Claudia, Roncador Giovanna, Sabattini Elena
Abstract excerpt
The differential diagnosis between lymphoplasmacytic lymphoma (LPL) and marginal zone B-cell lymphoma, particularly splenic type (SMZL), can be challenging on onset of bone marrow biopsy (BMB) since morphology and phenotype are not specific and clinical features can overlap or be mildly developed at diagnosis. The LPL-specific L265P mutation in the MYD88 gene is not available in all laboratories, and genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
